Nicolas Camper
Senior Director - Bioconjugation Chemistry Abzena
Seminars
Tuesday 13th October 2026
Streamlining Innovation in ADC Design Through Manufacturing With ThioBridge Conjugation & Linker Technology
11:30 am
- Delving into mechanistic insights of ThioBridge and advantages over conventional stochastic conjugation approaches, demonstrated through in vitro and in vivo ADC stability data
- Exploring how DAR can be precisely controlled using ThioBridge to optimize ADC therapeutic activity
- Assessing design strategies for optimizing linker-payload combinations to improve in vivo efficacy, supported by relevant preclinical data
- Manufacturing Considerations: Understanding key aspects of ThioBridge linker-payload and ADC manufacturing processes
